Rates and predictors of 30-day readmission among commercially insured and Medicaid-enrolled patients hospitalized with systolic heart failure.
about
Assessing Risk and Preventing 30-Day Readmissions in Decompensated Heart Failure: Opportunity to Intervene?B-type natriuretic peptide predicts 30-day readmission for heart failure but not readmission for other causes.Characterizing types of readmission after acute coronary syndrome hospitalization: implications for quality reportingPsychosocial characteristics and outcomes in patients with left ventricular assist device implanted as destination therapyPatient Characteristics Predicting Readmission Among Individuals Hospitalized for Heart Failure.Postdischarge environment following heart failure hospitalization: expanding the view of hospital readmission.The ninety-nine percent: focusing on the patient to reduce readmissionsDeterminants of survival following hospitalization for acute heart failure.Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement.All-Payer Analysis of Heart Failure Hospitalization 30-Day Readmission: Comorbidities Matter.Echocardiographic predictors of outcome in acute heart failure patients in sub-Saharan Africa: insights from THESUS-HFReadmission and Late Mortality After Critical Illness in Childhood.In-hospital use of non-steroidal anti-inflammatory drugs in patients with heart failure in academic centers in the United States.Heart failure readmissions.The national landscape of unplanned 30-day readmissions after total laryngectomy.Determining 30-day readmission risk for heart failure patients: the Readmission After Heart Failure scale.
P2860
Q26796380-5EEF2432-1DBF-42F1-BEE4-4423C4D7D515Q35021886-C8013503-8C1A-494C-867D-B53E2346535BQ35070858-6AF1FA7C-975C-44F5-B2A8-04F6128B7AC6Q36258969-AE19F76F-5BFB-44AA-AE6B-F08FD1EE7A2DQ36460004-84993F94-77A2-4103-B109-17348B9B0E3DQ36824765-DA288CBE-CCC4-438D-8EDD-6811FCEC2DCEQ37663106-F6B46B69-4C57-4323-A919-BCF3ED547912Q38183318-2316C617-50B4-4A68-B881-C35A00724045Q38789122-CE270CDA-4981-4BE2-8659-69D94D36CE61Q38807441-05D35823-C700-4A51-AECD-C72AFBBAC6ECQ38851058-277C30B0-3470-4EF7-BFA5-F06547F91DBCQ39009870-7F9A462F-4883-43B0-8CD0-5BE2B7F0E73EQ47926817-8D12A0A0-640E-4AF8-B6D6-59DE6BB5D507Q48003695-18DE8D0F-0EE5-4B8B-9566-6EFA10BF119DQ48274404-AA6B4456-AFBF-4DF1-81F8-CA3EC7525A83Q52579369-F568C483-33AB-4EA4-8AEC-AB66B664A756
P2860
Rates and predictors of 30-day readmission among commercially insured and Medicaid-enrolled patients hospitalized with systolic heart failure.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 October 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rates and predictors of 30-day ...... d with systolic heart failure.
@en
Rates and predictors of 30-day ...... d with systolic heart failure.
@nl
type
label
Rates and predictors of 30-day ...... d with systolic heart failure.
@en
Rates and predictors of 30-day ...... d with systolic heart failure.
@nl
prefLabel
Rates and predictors of 30-day ...... d with systolic heart failure.
@en
Rates and predictors of 30-day ...... d with systolic heart failure.
@nl
P2093
P2860
P921
P1476
Rates and predictors of 30-day ...... d with systolic heart failure.
@en
P2093
David M Smith
Irene Agodoa
Karen E Smoyer Tomic
Kathleen L Wilson
Larry A Allen
P2860
P304
P356
10.1161/CIRCHEARTFAILURE.112.967356
P577
2012-10-16T00:00:00Z